search
Back to results

Dry Needling in Subjects With Delayed Onset Muscle Soreness (TDNDOMS)

Primary Purpose

Delayed Onset Muscle Soreness

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Dry needling
Sham needling
Sponsored by
Bradley University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Delayed Onset Muscle Soreness

Eligibility Criteria

18 Years - 35 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • The participants of the study will be any healthy male or female between
  • age of 18 to 35
  • able and willing to perform an exercise protocol using the gastrocnemius muscle
  • willing to receive either sham or dry needling intervention

Exclusion Criteria:

  • current muscular pain
  • prior trigger point therapy in the past 6 months
  • medications that affect muscle function
  • injury in the past 6 months
  • any health condition that prevents exercising
  • recent surgery

Sites / Locations

  • Bradley University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

Dry needling

Sham needling

Arm Description

Dry needling intervention to the gastrocnemius muscle trigger point

Sham dry needling intervention to the gastrocnemius muscle trigger point

Outcomes

Primary Outcome Measures

Change in Biomechanical stiffness (N/m) using MyotonPRO
Measuring Biomechanical stiffness ( N/m) change at the following time frames

Secondary Outcome Measures

Change in Pressure pain threshold using pressure algometry
Measuring Pressure pain threshold change at the following time frames

Full Information

First Posted
February 5, 2019
Last Updated
July 26, 2023
Sponsor
Bradley University
search

1. Study Identification

Unique Protocol Identification Number
NCT03876080
Brief Title
Dry Needling in Subjects With Delayed Onset Muscle Soreness
Acronym
TDNDOMS
Official Title
Biomechanical Response to Dry Needling in Subjects With Delayed Onset Muscle Soreness: a Double Blind Randomized Control Trial
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Completed
Study Start Date
March 30, 2019 (Actual)
Primary Completion Date
May 23, 2023 (Actual)
Study Completion Date
May 23, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Bradley University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Investigation of the biomechanical response in delayed onset muscle soreness using dry needling vs. sham

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Delayed Onset Muscle Soreness

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
36 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Dry needling
Arm Type
Experimental
Arm Description
Dry needling intervention to the gastrocnemius muscle trigger point
Arm Title
Sham needling
Arm Type
Sham Comparator
Arm Description
Sham dry needling intervention to the gastrocnemius muscle trigger point
Intervention Type
Other
Intervention Name(s)
Dry needling
Intervention Description
The use of a solid filiform needle to treat trigger points
Intervention Type
Other
Intervention Name(s)
Sham needling
Intervention Description
Simulated needling
Primary Outcome Measure Information:
Title
Change in Biomechanical stiffness (N/m) using MyotonPRO
Description
Measuring Biomechanical stiffness ( N/m) change at the following time frames
Time Frame
baseline, immediately after intervention, 24 hours after intervention
Secondary Outcome Measure Information:
Title
Change in Pressure pain threshold using pressure algometry
Description
Measuring Pressure pain threshold change at the following time frames
Time Frame
baseline, immediately after intervention, 24 hours after intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: The participants of the study will be any healthy male or female between age of 18 to 35 able and willing to perform an exercise protocol using the gastrocnemius muscle willing to receive either sham or dry needling intervention Exclusion Criteria: current muscular pain prior trigger point therapy in the past 6 months medications that affect muscle function injury in the past 6 months any health condition that prevents exercising recent surgery
Facility Information:
Facility Name
Bradley University
City
Peoria
State/Province
Illinois
ZIP/Postal Code
61625
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Dry Needling in Subjects With Delayed Onset Muscle Soreness

We'll reach out to this number within 24 hrs